In the jejunal mucosa, the contents of pro-inflammatory cytokines IL-2, IL-6 and TNF-α were the lowest in COS1 supplementation group, especially the content of IL-6 was decreased by 81.03% compared with BD group (P < 0.05) (Figure 4E). This evidence concerns the gene IL6 and Behcet disease.